Vertex Pharmaceuticals Inc. buy BiotechBee
Start price
07.09.22
/
70%
€285.85
Target price
31.12.25
€400.00
Performance (%)
10.34%
End price
05.05.23
€315.40
Summary
This prediction ended on 05.05.23 with a price of €315.40. The prediction had a final performance of 10.34%. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Vertex Pharmaceuticals Inc. | -0.063% | -0.063% | -13.770% | 41.208% |
| iShares Core DAX® | -0.559% | 0.738% | 14.807% | 57.558% |
| iShares Nasdaq 100 | -0.566% | -0.324% | 3.991% | 86.023% |
| iShares Nikkei 225® | 1.073% | 5.624% | 19.546% | 49.340% |
| iShares S&P 500 | 0.868% | 0.030% | 1.475% | 58.072% |
According to BiotechBee what are the pros and cons of Vertex Pharmaceuticals Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Buy mit Kursziel 400,0